Long COVID

What is Long COVID?

Long COVID — formally known as Post-COVID Condition (PCC) by the World Health Organization — describes new, recurring, or ongoing symptoms that persist for more than 12 weeks after a SARS-CoV-2 infection that cannot be explained by an alternative diagnosis.

Long COVID emerged as a clinical reality early in the pandemic, named and popularised partly by patient communities who described their experiences online before medical research caught up. It is now recognised by the WHO, CDC, and major health agencies worldwide.

The scale is significant: estimates vary, but 10–30% of people infected with COVID-19 may develop some form of Long COVID, representing tens of millions of people globally. This makes it one of the largest new sources of disability in modern history.

How It Presents

Long COVID is characterised by an enormous range of symptoms — over 200 have been documented:

The most commonly reported include:

• Fatigue — profound, often post-exertional exhaustion that is disproportionate to activity
• Post-Exertional Malaise (PEM) — worsening of symptoms following physical or mental exertion, sometimes with a delay of 12–48 hours; this is also characteristic of ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome)
• Brain fog — difficulties with memory, concentration, word-finding, and processing speed
• Breathlessness — even at rest or with minor activity
• Palpitations and heart rate abnormalities — including POTS (Postural Orthostatic Tachycardia Syndrome)
• Chest pain
• Sleep disturbances
• Anxiety and depression
• Headaches
• Joint and muscle pain

Long COVID is often episodic and fluctuating — people may have good days and bad days, and may appear well while experiencing significant impairment.

Who Is Affected

Long COVID can affect people who had severe illness requiring hospitalisation, and those who had mild or even asymptomatic acute COVID-19. Women are disproportionately represented in Long COVID diagnoses. People from Black, Asian, and minority ethnic communities, and those from lower socioeconomic backgrounds, are also disproportionately affected — reflecting both COVID exposure patterns and barriers to healthcare.

Assistive Technology and Accommodations

Given the cognitive and fatigue symptoms, AT for Long COVID overlaps significantly with that for ME/CFS and fibromyalgia:

• Cognitive aids — reminder apps, note-taking tools, calendar systems to manage brain fog
• Voice control — reduces physical and cognitive demands of computer use
• Activity tracking apps — pace and monitor activity to avoid PEM crashes
• Wearables — heart rate monitors to identify when exertion is approaching unsafe levels (particularly for POTS)
• Remote and flexible work — often the critical accommodation; pace-of-work and rest-period flexibility
• Mobility aids — for those with significant physical limitations

Common Misconceptions

• "Long COVID is anxiety about COVID." Long COVID has documented physiological mechanisms — including viral persistence, immune dysregulation, microbiome disruption, and autonomic nervous system dysfunction.
• "If they got better from COVID, they should be fine now." Recovery from acute illness does not predict Long COVID risk or absence.
• "Pushing through fatigue will help recovery." In Long COVID — as in ME/CFS — pushing through post-exertional malaise can cause significant setbacks. Pacing is the most evidence-supported management strategy.

Language and Identity

The Long COVID community developed much of the early language around the condition — including "Long COVID" itself — through patient advocacy. Many people with Long COVID strongly identify as disabled and have become active advocates for disability rights and recognition, particularly around pacing, accessible workplaces, and the dismissal they experience in healthcare settings.